An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man.

[1]  A. Basit,et al.  Gut instincts: explorations in intestinal physiology and drug delivery. , 2008, International journal of pharmaceutics.

[2]  A. Basit,et al.  An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria. , 2008, Journal of pharmaceutical sciences.

[3]  A. Basit,et al.  Interplay Between Intestinal pH, Transit Time and Feed Status on the In Vivo Performance of pH Responsive Ileo-Colonic Release Systems , 2008, Pharmaceutical Research.

[4]  Yaochun Shen,et al.  Delayed release tablet dissolution related to coating thickness by terahertz pulsed image mapping. , 2008, Journal of pharmaceutical sciences.

[5]  Libo Yang,et al.  Biorelevant dissolution testing of colon-specific delivery systems activated by colonic microflora. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[6]  He Wei,et al.  In‐vitro and in‐vivo studies of pectin/ethylcellulose‐film‐coated pellets of 5‐fluorouracil for colonic targeting , 2008, The Journal of pharmacy and pharmacology.

[7]  A. Basit,et al.  An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. , 2006, Journal of pharmaceutical sciences.

[8]  E. McConnell,et al.  Colonic drug delivery using amylose films: the role of aqueous ethylcellulose dispersions in controlling drug release , 2006 .

[9]  A. Basit,et al.  A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. , 2006, International journal of pharmaceutics.

[10]  J. Varshosaz,et al.  Colon-specific delivery of mesalazine chitosan microspheres , 2006, Journal of microencapsulation.

[11]  N. Hosten,et al.  Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging , 2005, Alimentary pharmacology & therapeutics.

[12]  P. J. Wilson,et al.  Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets. , 2005, International journal of pharmaceutics.

[13]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[14]  S. Al-Saidan,et al.  In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery. , 2005, Current drug delivery.

[15]  J. Newton,et al.  Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. , 2004, International journal of pharmaceutics.

[16]  F. Podczeck,et al.  The use of formulation technology to assess regional gastrointestinal drug absorption in humans. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  J. Lee,et al.  Colon delivery of prednisolone based on chitosan coated polysaccharide tablets , 2002, Archives of pharmacal research.

[18]  F. Podczeck,et al.  The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37°C , 2002 .

[19]  J. Newton,et al.  Colonic delivery of 4‐aminosalicylic acid using amylose–ethylcellulose‐coated hydroxypropylmethylcellulose capsules , 2002, Alimentary pharmacology & therapeutics.

[20]  J. Newton,et al.  The Effect of Polyethylene Glycol 400 on Gastrointestinal Transit: Implications for the Formulation of Poorly-Water Soluble Drugs , 2001, Pharmaceutical Research.

[21]  R. Anziano,et al.  Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  J. Dressman,et al.  A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  S. Satyanarayana,et al.  Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[24]  D. Parkins,et al.  Pectin/Ethylcellulose Film Coating Formulations for Colonic Drug Delivery , 1996, Pharmaceutical Research.

[25]  W. Coward,et al.  In vivo studies of amylose- and ethylcellulose-coated [13C]glucose microspheres as a model for drug delivery to the colon , 1996 .

[26]  S. Bingham,et al.  Digestion and physiological properties of resistant starch in the human large bowel , 1996, British Journal of Nutrition.

[27]  H. Englyst,et al.  Measurement of resistant starch in vitro and in vivo , 1996, British Journal of Nutrition.

[28]  C. Neut,et al.  Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease , 1995, Digestive Diseases and Sciences.

[29]  F. Podczeck,et al.  The Description of the Gastrointestinal Transit of Pellets Assessed by Gamma Scintigraphy Using Statistical Moments , 1995, Pharmaceutical Research.

[30]  J. Newton,et al.  Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation , 1993 .

[31]  John H. Cummings,et al.  The amount and composition of large bowel contents in man , 1990 .

[32]  J. Hardcastle,et al.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.

[33]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[34]  H. Englyst,et al.  Starch utilization by the human large intestinal microflora. , 1986, The Journal of applied bacteriology.

[35]  J. Rhodes,et al.  An oral preparation to release drugs in the human colon. , 1982, British journal of clinical pharmacology.

[36]  A. Basit,et al.  Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers , 2005 .

[37]  A. Staib,et al.  Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device , 2004, European Journal of Clinical Pharmacology.

[38]  I. Wilding,et al.  Intestinal Performance of Two Mesalamine Formulations in Patients with Active Ulcerative Colitis as Assessed by Gamma Scintigraphy , 2003 .

[39]  H. Bernhardt,et al.  Mycological Aspects of Gastrointestinal Microflora. , 1997, Scandinavian journal of gastroenterology.

[40]  J. Newton,et al.  Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets , 1996 .

[41]  J. Newton,et al.  Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets , 1996 .

[42]  J. Newton,et al.  Development and in-vitro evaluation of a multiparticulate sustained release theophylline formulation , 1993 .

[43]  G. Simon,et al.  Intestinal flora in health and disease. , 1984, Gastroenterology.